Multi-Caregiving Intervention for Type 2 Diabetes Mellitus

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Type 2 Diabetes Mellitus+2 More
Multi-Caregiving Intervention - Behavioral
Eligibility
18 - 65
Female
What conditions do you have?
Select

Study Summary

This trial will compare the effects of two different interventions on African American women with diabetes who also have multi-caregiving responsibilities. One intervention will focus on social support and the other will focus on diabetes education and skills training.

Eligible Conditions
  • Type 2 Diabetes Mellitus

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: Screening/Baseline, 3-months, 6-months

Screening/Baseline, 3-months, 6-months
Change in Blood Glucose Monitoring from Baseline to 6 months
Change in Blood Pressure Control from Baseline to 6 months
Change in Diet from Baseline to 6 months
Change in Glycemic Control from Baseline to 6 months
Change in Health Related Quality of Life from Baseline to 6 months
Change in Medication Adherence from Baseline to 6 months
Change in Physical Activity from Baseline to 6 months

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Diabetes Enhanced Usual Care Intervention
1 of 2
Multi-Caregiving Intervention
1 of 2

Active Control

Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Multi-Caregiving Intervention · No Placebo Group · N/A

Multi-Caregiving Intervention
Behavioral
Experimental Group · 1 Intervention: Multi-Caregiving Intervention · Intervention Types: Behavioral
Diabetes Enhanced Usual Care Intervention
Behavioral
ActiveComparator Group · 1 Intervention: Diabetes Enhanced Usual Care Intervention · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: screening/baseline, 3-months, 6-months

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
554 Previous Clinical Trials
1,152,112 Total Patients Enrolled
9 Trials studying Type 2 Diabetes Mellitus
1,312 Patients Enrolled for Type 2 Diabetes Mellitus
Joni Williams, MD, MPHPrincipal InvestigatorMedical College of Wisconsin

Eligibility Criteria

Age 18 - 65 · Female Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You self-identify as African American or Non-Hispanic Black.
You have self-reported multiple caregiving responsibilities.
You have access to a telephone.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 31st, 2021

Last Reviewed: November 1st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.